Gerhardt Axel, Feisst Manuel, Strowitzki Thomas, Zivanovic Oliver, Weinschenk Stefan
Gynecological Pain Clinic, Department of General Gynecology, Women's Hospital, Im Neuenheimer Feld 440, 69120, Heidelberg, Germany.
On Behalf of the Heidelberg University Neural Therapy Education and Research Group (HUNTER Group), Im Neuenheimer Feld 440, 69120, Heidelberg, Germany.
Pain Ther. 2025 Jun;14(3):1025-1043. doi: 10.1007/s40122-025-00725-7. Epub 2025 Apr 3.
Vulvodynia is a debilitating sexual disorder with a high prevalence of 7-11%. In the study reported here, we analyzed long-term results from a prospective, non-controlled observational study to enhance our understanding of the success of therapeutic local anesthesia (TLA) and to investigate factors that predict a response or failure of therapy, with the overall aim to gain new insights into the complex medical condition of vulvodynia.
A total of 45 patients diagnosed with severe chronic vulvodynia or chronic vulvar pain (Numeric Analog Scale [NAS] ≥ 6, median 7.9, duration ≥ 6 months, median 65.2 months) and previously treated with TLA were re-evaluated 4.5-13 years after therapy. Therapy response was defined as NAS ≤ 4 for at least 6 months.
Of the 45 patients originally diagnosed with vulvodynia, 38 were available for follow-up (32 of the original 36 responders, and 4 of the 9 non-responders). The average follow-up period was 7.9 years (95.2 months, range 55-156 months) after the end of therapy. All responders remained symptom-free, and two of the non-responders also became responders. Factors associated with non-response were: the number of physicians seen previously, lichen sclerosus, previous traumata, relapses of recurrent cystitis, corticoid therapy, and psychological factors, including depression, psychotropic drug intake, and psychotherapy. Body mass index (BMI) was lower in non-responders. The number of deliveries, cesarean sections, abortions, age, hormonal status, other medication intake, and gynecological surgeries had no impact on the results.
The long-term success of TLA supports the hypothesis that neuralgia of one or more nerves of the pelvic floor is an important component in the development of vulvodynia. This study provides evidence for the long-term effectiveness of TLA in women with vulvodynia, as well as potential obstacles to healing. Despite limitations imposed by a monocentric, non-controlled observational design, the robustness of this investigation lies in the long observation period after treatment and the substantial percentage of patients for whom TLA was successful. The long-term results emphasize the necessity of a holistic approach integrating the view of vulvodynia as a peripheral neuro-functional disorder.
外阴痛是一种使人衰弱的性功能障碍,患病率高达7%-11%。在本报告的研究中,我们分析了一项前瞻性、非对照观察性研究的长期结果,以加深我们对治疗性局部麻醉(TLA)成功情况的理解,并调查预测治疗反应或失败的因素,总体目标是对外阴痛这一复杂病症获得新的认识。
共有45例被诊断为重度慢性外阴痛或慢性外阴疼痛(数字模拟量表[NAS]≥6,中位数为7.9,病程≥6个月,中位数为65.2个月)且先前接受过TLA治疗的患者在治疗后4.5 - 13年进行了重新评估。治疗反应定义为NAS≤4至少持续6个月。
最初被诊断为外阴痛的45例患者中,38例可供随访(最初36例有反应者中的32例,9例无反应者中的4例)。治疗结束后的平均随访期为7.9年(95.2个月,范围55 - 156个月)。所有有反应者均保持无症状,2例无反应者也变成了有反应者。与无反应相关的因素有:之前看过的医生数量、硬化性苔藓、既往创伤、复发性膀胱炎复发、皮质类固醇治疗以及心理因素,包括抑郁、服用精神药物和接受心理治疗。无反应者的体重指数(BMI)较低。分娩次数、剖宫产次数、流产次数、年龄、激素状态、其他药物摄入以及妇科手术对结果均无影响。
TLA的长期成功支持了这样一种假设,即盆底一条或多条神经的神经痛是外阴痛发生的一个重要组成部分。本研究为TLA对外阴痛女性的长期有效性以及潜在的愈合障碍提供了证据。尽管单中心、非对照观察性设计存在局限性,但本研究的优势在于治疗后的长期观察期以及TLA成功治疗的患者比例较高。长期结果强调了将外阴痛视为一种周围神经功能障碍的整体方法的必要性。